Lopez P, Espinosa M, Greenberg B, Lacks S A
J Bacteriol. 1987 Sep;169(9):4320-6. doi: 10.1128/jb.169.9.4320-4326.1987.
A chromosomal gene of Streptococcus pneumoniae carrying a spontaneous mutation to sulfonamide resistance was identified. Comparison of its DNA sequence with the wild-type sequence showed that the mutation, sul-d, consisted of an insert of 6 base pairs, a repeat of an adjacent 6-base-pair segment. The gene encoded a 34-kilodalton polypeptide, SulA, which as a dimer or trimer constituted the enzyme dihydropteroate synthase. This was shown by enzyme activity measurements, expression in minicells of Bacillus subtilis, and the amino-terminal sequence of the polypeptide product. Subcloning of the gene in an Escherichia coli expression vector allowed purification of the enzyme to 80% homogeneity in a single step and at high yield. Although a deleted plasmid, pLS83, produced the mutant dihydropteroate synthase, it did not confer sulfonamide resistance in vivo. It is suggested that the SulA polypeptide is also a component of an enzyme that acts in another step of folate biosynthesis and that this step is inhibited in vivo by either free or conjugated sulfonamides.
鉴定出肺炎链球菌中一个携带对磺胺类药物耐药性自发突变的染色体基因。将其DNA序列与野生型序列进行比较,结果表明该突变体sul-d由一个6个碱基对的插入片段以及相邻6个碱基对片段的重复组成。该基因编码一种34千道尔顿的多肽SulA,其作为二聚体或三聚体构成二氢蝶酸合酶。这通过酶活性测定、在枯草芽孢杆菌微小细胞中的表达以及多肽产物的氨基末端序列得以证实。将该基因亚克隆到大肠杆菌表达载体中,可一步实现该酶的纯化,纯度达到80%,且产量很高。尽管缺失质粒pLS83可产生突变型二氢蝶酸合酶,但它在体内并未赋予磺胺类药物抗性。这表明SulA多肽也是在叶酸生物合成的另一步骤中起作用的一种酶的组成成分,并且该步骤在体内会被游离或结合的磺胺类药物抑制。